Hyperuricemia

Factors Associated With Bone Erosion Identified in Gout

Publish Date January 25, 2019

Investigators evaluated the prevalence, distribution, and factors associated with bone erosion detectable by ultrasound in patients with gout.

High Uric Acid Predicts AKI, Mortality in Hospitalized Patients

Publish Date January 18, 2019

Hospitalized men and women in the highest quartile of serum uric acid had a 3-fold higher risk of acute kidney injury than those in the lowest quartile.

High Uric Acid May Up Cardiovascular Mortality in CKD

Publish Date January 17, 2019

In a meta-analysis, the risk for cardiovascular mortality increased a significant 12% for every 1 mg/dL increase in uric acid.

Gout Linked to Elevated Risk of Parkinson’s Disease

Publish Date January 14, 2019

Investigators report a significant 27% increased risk of Parkinson’s disease among individuals aged 65 years and older but less than 75 years.

Gout Tied With Worse Outcomes in Obstructive Coronary Artery Disease

Publish Date November 27, 2018

A history of gout was associated with worse outcomes in patients with obstructive coronary artery disease.

Gout Increases Chronic Kidney Disease Risk

Publish Date November 6, 2018

In an observational UK study, chronic kidney disease stage 3 or higher was 78% more likely to develop in patients with vs without gout during a median follow-up of 6 years.

Allopurinol Linked to Reduced Risk for CKD Stage ≥3 in Gout

Publish Date October 30, 2018

Allopurinol use is not associated with renal function decline among those with newly diagnosed gout.

High Gout Burden Found Among Solid Organ Transplant Recipients

Publish Date October 27, 2018

Study reveals an 11% prevalence of active gout among solid organ transplant recipients overall and a 13% prevalence among kidney transplant recipients.

High Uric Acid Raises Death Risk in CKD

Publish Date October 26, 2018

Patients with chronic kidney disease who have hyperuricemia have a 3-fold higher risk of all-cause mortality.

Febuxostat Increases CV Event Risk Only in Established CV Disease

Publish Date October 23, 2018

Spanish study found no significant difference between febuxostat and allopurinol with respect to risk of new cardiovascular events among gout patients without prior cardiovascular disease.